Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Maculopapular drug eruption in a patient with human immunodeficiency virus (HIV) infection, wasting syndrome and pulmonary tuberculosis: A case report

Jurnal kedokteran dan kesehatan Indonesia (2023) · hlm. 357–364

DOI
10.20885/jkki.vol14.iss3.art16
ISSN
2085-4145, 2527-2950
Terbit
2023-12-30
Penerbit
Islamic University of Indonesia
Bahasa
en
Lisensi
creativecommons.org/licenses/by/4.0/

Abstrak

Maculopapular drug eruption (MDE) is the most typical type of hypersensitivity reaction. Patients with human immunodeficiency virus (HIV) infection may develop some complications, including wasting syndrome, contributing to immune system dysregulation. The late stage of HIV infection increases the risk of pulmonary tuberculosis (TB), in which the administration of anti-tuberculosis drugs (ATD) often induces drug eruptions. A 41-year-old man complained of itchy skin rash on his hands, body, and feet. The rash appeared after a streptomycin injection on the 9th day, accompanied by complaints of fever, weakness, dizziness, and chronic cough followed by fever at night. The patient was treated and diagnosed with a new case of pulmonary TB; and he also received first-line ATD. The streptomycin injection was given because systemic manifestation still appeared. The researchers diagnosed the patient with HIV infection with wasting syndrome. He was hospitalized and given methylprednisolone injection, paracetamol infusion, omeprazole injection, oral cetirizine, and moisturizer. After that, clinical improvement occurred, and he was discharged on the fourth day. Patients with HIV infection often develop MDE. Clinical manifestations of maculopapular drug eruption are generally mild without systemic complaints; however, in certain conditions, such as HIV infection with wasting syndrome, more severe systemic symptoms can appear due to excess secretion of several proinflammatory cytokines. Several studies have also reported an increased incidence of maculopapular drug eruption caused by first-line anti-HIV drugs, especially in patients with HIV infection.

Kata kunci

Jaringan kolaborasi para penulis

17 penulis · 44 tautan kepenulisan bersama · 4 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Sebelas Maret University
  • Jenderal Soedirman University
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Faizal MuhammadSebelas Maret University1
Coana SukmagautamaSebelas Maret University1
Ken Zuraida MaharestriSebelas Maret University1
Risalina MyrthaSebelas Maret University1
Fitranto ArjadiJenderal Soedirman University1
Thianti SylviningrumJenderal Soedirman University1
Ismiralda Oke PutrantiJenderal Soedirman University1
Octavia Permata SariJenderal Soedirman University1
Sugih Primas AdjieSebelas Maret University1
Nugrohoaji DharmawanSebelas Maret University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210214198, pertama di-harvest 20 Nov 2026, terakhir terlihat 20 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Maculopapular drug eruption in a patient with human immunodeficiency virus (HIV) infection, wasting syndrome and pulmonary tuberculosis: A case report</dc:title><dc:creator>Triasari Oktavriana</dc:creator><dc:creator>Bobby Febrianto</dc:creator><dc:creator>Ihsan Hanif</dc:creator><dc:creator>Azhar Arrosyid</dc:creator><dc:creator>Lian Kamilah</dc:creator><dc:creator>Fanny Fauziyyah Heryadi</dc:creator><dc:creator>Harijono Kariosentono</dc:creator><dc:subject>HIV infection</dc:subject><dc:subject>cachexia</dc:subject><dc:subject>pulmonary tuberculosis</dc:subject><dc:subject>streptomycin</dc:subject><dc:subject>antitubercular agents</dc:subject><dc:subject>drug hypersensitivity</dc:subject><dc:subject>inflammatory cytokines</dc:subject><dc:subject>immune dysregulation</dc:subject><dc:description xml:lang="en">Maculopapular drug eruption (MDE) is the most typical type of hypersensitivity reaction. Patients with human immunodeficiency virus (HIV) infection may develop some complications, including wasting syndrome, contributing to immune system dysregulation. The late stage of HIV infection increases the risk of pulmonary tuberculosis (TB), in which the administration of anti-tuberculosis drugs (ATD) often induces drug eruptions. A 41-year-old man complained of itchy skin rash on his hands, body, and feet. The rash appeared after a streptomycin injection on the 9th day, accompanied by complaints of fever, weakness, dizziness, and chronic cough followed by fever at night. The patient was treated and diagnosed with a new case of pulmonary TB; and he also received first-line ATD. The streptomycin injection was given because systemic manifestation still appeared. The researchers diagnosed the patient with HIV infection with wasting syndrome. He was hospitalized and given methylprednisolone injection, paracetamol infusion, omeprazole injection, oral cetirizine, and moisturizer. After that, clinical improvement occurred, and he was discharged on the fourth day. Patients with HIV infection often develop MDE. Clinical manifestations of maculopapular drug eruption are generally mild without systemic complaints; however, in certain conditions, such as HIV infection with wasting syndrome, more severe systemic symptoms can appear due to excess secretion of several proinflammatory cytokines. Several studies have also reported an increased incidence of maculopapular drug eruption caused by first-line anti-HIV drugs, especially in patients with HIV infection.</dc:description><dc:publisher>Islamic University of Indonesia</dc:publisher><dc:date>2023-12-30</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20885/jkki.vol14.iss3.art16</dc:identifier><dc:identifier>10.20885/jkki.vol14.iss3.art16</dc:identifier><dc:source>Jurnal kedokteran dan kesehatan Indonesia; (2023); 357-364</dc:source><dc:source>2085-4145</dc:source><dc:source>2527-2950</dc:source><dc:language>en</dc:language><dc:relation>https://journal.uii.ac.id/JKKI/article/download/26052/16080</dc:relation><dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights></oai_dc:dc>